Cxbladder Bulletin - October 2024
26th October 2024
Pacific Edge invites you to read the October 2024 edition of our Cxbladder Bulletin newsletter. Read More
Real World Evidence for Cxbladder to Feature at WSAUA
24th October 2024
New data demonstrating the clinical and economic value of Pacific Edge’s Cxbladder cancer diagnostic tests will be in the spotlight at the 100th annual meeting for the Western Section of the American Urological Association (WSAUA) in Kauai, Hawaii. Read More
Pacific Edge on the Podium at UAA in Bali
03rd September 2024
Pacific Edge CEO to present data from its recently published STRATA study at the Urological Association of Asia (UAA) Congress and attended signing event for lab partnership agreement in Malaysia. Read More
AUA Journal of Urology Editorial Supports Cxbladder
13th August 2024
Pacific Edge welcomes an editorial in the American Urological Association’s Journal of Urology supporting the use of Cxbladder to reduce unnecessary cystoscopies on patients at risk of bladder cancer. Read More
Survey: Surveillance Patients Show Strong Interest in Non-Invasive Test Options
12th June 2024
In December 2023, using the Bladder Cancer Advocacy Network’s (BCAN’s) Patient Survey Network, we surveyed 1,507 US patients being monitored for non-muscle invasive bladder cancer (NMIBC). Those surveyed displayed a strong interest in non-invasive test options. Read More
Cxbladder Bulletin - May 2024
31st May 2024
Pacific Edge invites you to read the May 2024 edition of the Cxbladder Bulletin newsletter. Read More
Clinical Utility of Cxbladder to Headline at AUA 2024
30th April 2024
A ground-breaking study demonstrating the clinical utility of Cxbladder is to be the centrepiece of Pacific Edge’s activities at the 2024 American Urological Association (AUA) Annual Meeting to be held May 3 – 6 in San Antonio, Texas. Read More
Cxbladder Bulletin - March 2024
22nd March 2024
Pacific Edge invites you to read the March 2024 edition of the Cxbladder Bulletin newsletter. Read More